The largest database of trusted experimental protocols

Sureselect human exome kit v6

Manufactured by Agilent Technologies

The SureSelect Human Exome Kit (V6) is a targeted enrichment solution designed for capturing the protein-coding regions of the human genome, known as the exome. The kit utilizes in-solution hybridization technology to selectively capture and enrich the exonic regions of the human genome, allowing for efficient and cost-effective sequencing of the exome.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using sureselect human exome kit v6

1

Coding Sequence Analysis of BLM in Hereditary Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
We analyzed the entire coding sequence of BLM from the exome sequencing data of 617 women with hereditary breast cancer (step 1) as described previously [33 (link)]. The Agilent SureSelect human exome kit (V6) was used for capturing target regions. The regions were sequenced on Illumina NextSeq 500. The mean depth of coverage was approximately 100×, 97.4% of the CCDS exons were covered at 20× depth of coverage and higher, which was used for variant calling. We looked for protein truncating genetic variants, including frame shift insertions, deletions, stop codon mutations, and variants at the consensus splice sites, which are likely to be dysfunctional.
+ Open protocol
+ Expand
2

Exome Sequencing of APOBEC3B in Hereditary Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
We analyzed the entire coding sequence of APOBEC3B from the exome sequencing data of 617 women with hereditary breast cancer (step 1), as described previously [45 (link)]. The Agilent SureSelect human exome kit (V6) was used for capturing target regions. The regions were sequenced on Illumina NextSeq 500. The mean depth of coverage was approximately 100×, 97.4% of the CCDS exons were covered at 20× depth of coverage and higher which is used for variant calling. We looked for protein-truncating genetic variants, including frameshift insertions, deletions, stop codon mutations, and variants at the consensus splice sites, which are likely to be dysfunctional.
+ Open protocol
+ Expand
3

Comprehensive XRCC2 Exome Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We analyzed the entire coding sequence of XRCC2 from the exome sequencing data of 617 women with hereditary breast cancer (cases series 1) using the methodology described previously [16 (link)]. In brief, the Agilent SureSelect human exome kit (V6) was used for capturing target regions. The regions were sequenced on Illumina NextSeq 500. The mean depth of coverage was approximately × 100; 97.4% of the CCDS exons were covered at × 20 depth of coverage and higher which used for variant calling.
+ Open protocol
+ Expand
4

Exome Sequencing of Hereditary Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The first series of 390 men with hereditary prostate cancer were tested by exome sequencing as described previously [39 (link)]. In brief, The Agilent SureSelect human exome kit (V6) was used for capturing sequence target regions. Paired-end sequencing was performed on a high throughput sequencing cartridge of Illumina NextSeq 500. The mean depth of coverage was approximately 100× (range 62× to 171×). On average, 98.8% (range 87.6% to 99.0%) of the CCDS exons were covered at 20x depth of coverage and higher which used for variant calling. We sought to identify protein truncating variants, variants at the consensus splice site likely to be dysfunctional and known pathogenic missense or intronic mutations in BARD1 gene based on the literature, ClinVar and Human Genome Mutation Database.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!